Evangelos Hytopoulos

698 total citations
21 papers, 452 citations indexed

About

Evangelos Hytopoulos is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Computational Theory and Mathematics. According to data from OpenAlex, Evangelos Hytopoulos has authored 21 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Computational Theory and Mathematics. Recurrent topics in Evangelos Hytopoulos's work include Computational Drug Discovery Methods (6 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Evangelos Hytopoulos is often cited by papers focused on Computational Drug Discovery Methods (6 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Evangelos Hytopoulos collaborates with scholars based in United States, Australia and Sweden. Evangelos Hytopoulos's co-authors include Ellen L. Berg, Eric J. Kunkel, Ivan Plavec, Jennifer Melrose, Eugene C. Butcher, Carlos Iribarren, Dat Nguyen, Thomas Quertermous, Philip S. Tsao and Edward R. McCluskey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Evangelos Hytopoulos

19 papers receiving 399 citations

Peers

Countries citing papers authored by Evangelos Hytopoulos

Since Specialization

Citations

This map shows the geographic impact of Evangelos Hytopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evangelos Hytopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evangelos Hytopoulos more than expected).

Fields of papers citing papers by Evangelos Hytopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evangelos Hytopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evangelos Hytopoulos. The network helps show where Evangelos Hytopoulos may publish in the future.

Co-authorship network of co-authors of Evangelos Hytopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Evangelos Hytopoulos. A scholar is included among the top collaborators of Evangelos Hytopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evangelos Hytopoulos. Evangelos Hytopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reproducible Reporting of the Collection and Evaluation of Annotations for Artificial Intelligence Models 2024 ·Modern Pathology ·(unknown), (unknown), Víctor García, Amy Ly, Evangelos Hytopoulos, (unknown), Matthew G. Hanna, Dieter Peeters, Joel Saltz, Anna Ehinger, Sarah Dudgeon, Xiaoxian Li, Kim Blenman, Weijie Chen, Ursula Green, (unknown), Tony Pan, Jochen K. Lennerz, Roberto Salgado, Brandon D. Gallas	6
2	Performance of Ambulatory Electrocardiographic Data for Prediction of Stroke and Heart Failure Events 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Bradley G. Hammill, Amy G. Clark, Sean D. Pokorney, Evangelos Hytopoulos, Mintu P. Turakhia, (unknown), Jonathan P. Piccini	0
3	Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The mSToPS Study 2023 ·Circulation Cardiovascular Quality and Outcomes ·Matthew R. Reynolds, Joshua Epstein, Xiaowu Sun, Evangelos Hytopoulos, Steven R. Steinhubl, David J. Cohen	4
4	Abstract 12649: Harnessing Ambulatory Monitoring Data to Improve Prediction of Heart Failure 2023 ·Circulation ·(unknown), (unknown), Bradley G. Hammill, Amy G. Clark, Sean D. Pokorney, Melissa A. Greiner, Evangelos Hytopoulos, Mintu P. Turakhia, (unknown), Jonathan P. Piccini	1
5	Prediction of atrial fibrillation from at-home single-lead ECG signals without arrhythmias 2023 ·npj Digital Medicine ·Matteo Gadaleta, Patrick Harrington, Eric Barnhill, Evangelos Hytopoulos, Mintu P. Turakhia, Steven R. Steinhubl, Giorgio Quer	32
6	Initial interactions with the FDA on developing a validation dataset as a medical device development tool 2023 ·The Journal of Pathology ·Steven N. Hart, Víctor García, Sarah Dudgeon, Matthew G. Hanna, Xiaoxian Li, Kim Blenman, (unknown), Amy Ly, Roberto Salgado, Joel Saltz, Rajarsi Gupta, Evangelos Hytopoulos, Denis Larsimont, Jochen K. Lennerz, Brandon D. Gallas	1
7	Pilot study to evaluate tools to collect pathologist annotations for validating machine learning algorithms 2022 ·Journal of Medical Imaging ·(unknown), Sarah Dudgeon, Víctor García, Kim Blenman, Evangelos Hytopoulos, (unknown), Xiaoxian Li, Amy Ly, (unknown), (unknown), Mohamed Amgad, Rajarsi Gupta, Joel Saltz, Matthew G. Hanna, Anna Ehinger, Dieter Peeters, Roberto Salgado, Brandon D. Gallas	3
8	Clinical and Analytical Validation of a Novel Urine-Based Test for the Detection of Allograft Rejection in Renal Transplant Patients 2020 ·Journal of Clinical Medicine ·Niamh Nolan, (unknown), (unknown), Joshua Yang, Reuben D. Sarwal, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Evangelos Hytopoulos, Minnie Sarwal	22
9	Analytical Validation of Relative Average Telomere Length Measurement in a Clinical Laboratory Environment 2017 ·The Journal of Applied Laboratory Medicine ·(unknown), Clare L. Fasching, Jue Lin, Karl Guegler, Evangelos Hytopoulos, Drew Watson, Calvin B. Harley	1
10	Clinical Utility of a Novel Coronary Heart Disease Risk‐Assessment Test to Further Classify Intermediate‐Risk Patients 2013 ·Clinical Cardiology ·Matthew D. Solomon, (unknown), Evangelos Hytopoulos, Michael Beggs, Douglas S. Harrington, Cynthia French, Thomas Quertermous	5
11	Analytical performance validation of a coronary heart disease risk assessment multi-analyte proteomic test 2012 ·Expert Opinion on Medical Diagnostics ·Niamh Nolan, (unknown), (unknown), Ivana Burazor, Evangelos Hytopoulos, William Biggs, Michael Beggs, Cynthia French, Douglas S. Harrington	2
12	Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts 2012 ·Current Medical Research and Opinion ·Deanna Cross, Catherine A. McCarty, Evangelos Hytopoulos, Michael Beggs, Niamh Nolan, Douglas S. Harrington, Trevor Hastie, Robert Tibshirani, Russell P. Tracy, Bruce M. Psaty, Robyn L. McClelland, Philip S. Tsao, Thomas Quertermous	26
13	Circulating Angiopoietins-1 and -2, Angiopoietin Receptor Tie-2 and Vascular Endothelial Growth Factor-A as Biomarkers of Acute Myocardial Infarction: a Prospective Nested Case-Control Study 2011 ·BMC Cardiovascular Disorders ·Carlos Iribarren, Bruce H. Phelps, Jeanne Darbinian, Edward R. McCluskey, Charles P. Quesenberry, Evangelos Hytopoulos, Joseph H. Vogelman∥, Norman Orentreich∥	52
14	Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease 2007 ·Physiological Genomics ·Diego Ardigò, Themistocles L. Assimes, Stephen P. Fortmann, Alan S. Go, Mark A. Hlatky, Evangelos Hytopoulos, Carlos Iribarren, Philip S. Tsao, Raymond Tabibiazar, Thomas Quertermous	57
15	Characterization of compound mechanisms and secondary activities by BioMAP analysis 2005 ·Journal of Pharmacological and Toxicological Methods ·Ellen L. Berg, Eric J. Kunkel, Evangelos Hytopoulos, Ivan Plavec	50
16	Biological complexity and drug discovery: a practical systems biology approach 2005 ·PubMed ·Ellen L. Berg, Eric J. Kunkel, Evangelos Hytopoulos	20
17	Rapid Structure-Activity and Selectivity Analysis of Kinase Inhibitors by BioMAP Analysis in Complex Human Primary Cell-Based Models 2004 ·Assay and Drug Development Technologies ·Eric J. Kunkel, Ivan Plavec, Dat Nguyen, Jennifer Melrose, Elen Rosler, (unknown), (unknown), Evangelos Hytopoulos, Anthony C. Bishop, Raynard L. Bateman, Kevan M. Shokat, Eugene C. Butcher, Ellen L. Berg	65
18	An integrative biology approach for analysis of drug action in models of human vascular inflammation 2004 ·The FASEB Journal ·Eric J. Kunkel, (unknown), Allen Ebens, Evangelos Hytopoulos, Jennifer Melrose, Dat Nguyen, (unknown), Ivan Plavec, (unknown), Susan R. Watson, Eugene C. Butcher, Ellen L. Berg	63
19	Method for analyzing signaling networks in complex cellular systems 2004 ·Proceedings of the National Academy of Sciences ·Ivan Plavec, Oksana Sirenko, (unknown), (unknown), Maya Dajee, Jennifer Melrose, (unknown), Evangelos Hytopoulos, Ellen L. Berg, Eugene C. Butcher	36
20	Rapid Structure-Activity and Selectivity Analysis of Kinase Inhibitors by BioMAP Analysis in Complex Human Primary Cell-Based Models 2004 ·Assay and Drug Development Technologies ·Eric J. Kunkel, Ivan Plavec, Dat Tien Nguyen, Jennifer Melrose, Elen Rosler, (unknown), (unknown), Evangelos Hytopoulos, Anthony C. Bishop, Raynard L. Bateman, Kevan M. Shokat, Eugene C. Butcher, Ellen L. Berg	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact